L. Payen-Gay

The cytosolic 5′-nucleotidase cN-II lowers the adaptability to glucose deprivation in human breast cancer cells

C. Dumontet, L. Jordheim, E. Cros-Perrial, 2017, Oncotarget.

Oncogene- and drug resistance-associated alternative exon usage in acute myeloid leukemia (AML)

D. Auboeuf, M. Thénoz, E. Wattel, 2015, Oncotarget.

Quantification of the organophosphate flame retardant triphenylphosphate and its main metabolite in whole blood by liquid–liquid micro-extraction and liquid chromatography-tandem mass spectrometry

Arnaud M. Vigneron, B. Giroud, A. Buleté, 2021 .

TET2 exon 2 skipping is an independent favorable prognostic factor for cytogenetically normal acute myelogenous leukemia (AML): TET2 exon 2 skipping in AML.

D. Maucort-Boulch, D. Auboeuf, E. Wattel, 2017, Leukemia research.

Issues and limitations of available biomarkers for fluoropyrimidine-based chemotherapy toxicity, a narrative review of the literature

J. Guitton, G. Grenet, J. Lega, 2021, ESMO open.

Circulating H3K27 Methylated Nucleosome plasma concentration: a synergic information with ctDNA Molecular Profiling

C. Haon, C. Rodriguez-Lafrasse, S. Couraud, 2023, medRxiv.

Circulating H3K27 Methylated Nucleosome Plasma Concentration: Synergistic Information with Circulating Tumor DNA Molecular Profiling

C. Rodriguez-Lafrasse, S. Couraud, F. Subtil, 2023, Biomolecules.